WO2009057137A4 - A process for the purification of levetiracetam - Google Patents

A process for the purification of levetiracetam Download PDF

Info

Publication number
WO2009057137A4
WO2009057137A4 PCT/IN2008/000523 IN2008000523W WO2009057137A4 WO 2009057137 A4 WO2009057137 A4 WO 2009057137A4 IN 2008000523 W IN2008000523 W IN 2008000523W WO 2009057137 A4 WO2009057137 A4 WO 2009057137A4
Authority
WO
WIPO (PCT)
Prior art keywords
levetiracetam
purification
filtering
iii
residue
Prior art date
Application number
PCT/IN2008/000523
Other languages
French (fr)
Other versions
WO2009057137A3 (en
WO2009057137A2 (en
Inventor
Keshav Deo
Killol Patel
Dharmesh Balvantrai Mistry
Original Assignee
Alembic Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alembic Limited filed Critical Alembic Limited
Publication of WO2009057137A2 publication Critical patent/WO2009057137A2/en
Publication of WO2009057137A3 publication Critical patent/WO2009057137A3/en
Publication of WO2009057137A4 publication Critical patent/WO2009057137A4/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/272-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Present invention relates to an improved process for the purification of Levetiracetam of formula (I).

Claims

AMENDED CLAIMS received by the International Bureau on 26 August 2009 (26.08.2009); original claims 6-10 deleted; remaining claims unchanged-
5. A process for the purification of Levetiracetam comprising steps of:
(i) treating substantially impure Levetiracetam with acetic acid and activated carbon in a methyl tertiary butyl ether, (ii) stirring and filtering the mixture obtained in step (i)
(iii) evaporating the filtrate of step (ii) to obtain a residue (iv) adding ethyl acetate to the residue obtained in step (iii) to obtain solution (v) refluxing and cooling the solution obtained in step (iv)
(vi) filtering and drying a solid obtained in step (v) to obtain Levetiracetam (I) having purity at least 99.5 %.
PCT/IN2008/000523 2007-08-22 2008-08-21 A process for the purification of levetiracetam WO2009057137A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1610/MUM/2007 2007-08-22
IN1610MU2007 2007-08-22

Publications (3)

Publication Number Publication Date
WO2009057137A2 WO2009057137A2 (en) 2009-05-07
WO2009057137A3 WO2009057137A3 (en) 2009-08-06
WO2009057137A4 true WO2009057137A4 (en) 2009-10-22

Family

ID=40591605

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2008/000523 WO2009057137A2 (en) 2007-08-22 2008-08-21 A process for the purification of levetiracetam

Country Status (1)

Country Link
WO (1) WO2009057137A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101885696A (en) * 2009-05-14 2010-11-17 上海华理生物医药有限公司 Method for synthesizing high-purity levetiracetam
CN103922988A (en) * 2014-04-29 2014-07-16 苏州天马精细化学品股份有限公司 Method for purifying levetiracetam crude product
CN114560800A (en) * 2022-03-03 2022-05-31 吉林省博大制药股份有限公司 Production method of levetiracetam bulk drug

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1517893A2 (en) * 2003-02-03 2005-03-30 Teva Pharmaceutical Industries Limited Process for producing levetiracetam
EP1663968A1 (en) * 2003-09-05 2006-06-07 Ranbaxy Laboratories Limited Process for the preparation of pure levetiracetam
WO2007080470A2 (en) * 2006-01-16 2007-07-19 Orchid Chemicals & Pharmaceuticals Limited A method for the purification of levetiracetam

Also Published As

Publication number Publication date
WO2009057137A3 (en) 2009-08-06
WO2009057137A2 (en) 2009-05-07

Similar Documents

Publication Publication Date Title
CN1097583C (en) Process for preparing intermediates to florfenicol
UA92171C2 (en) Method for preparation of optionally 2-substituted 1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acids
WO2007103024A8 (en) Polycarboxylic acid production system employing cooled mother liquor from oxidative digestion as feed to impurity purge system
CN104418841B (en) A kind of preparation method of optical pure rebeprazole and its sodium salt
WO2009057137A4 (en) A process for the purification of levetiracetam
CN105063120A (en) Preparation method of levetiracetam
WO2007049295A3 (en) An improved one pot process for making key intermediate for gemcitabine hcl
CN102453011A (en) Preparation method of high-purity naringenin
CN102311394B (en) Preparation method for 5-ethyl-5-phenyl barbituric acid
CA2676443A1 (en) Atorvastatin calcium propylene glycol solvates
EP2457899A1 (en) Process for production of optically active nipecotamide
TWI341315B (en) Process for the preparation of poly (silyl ester) s, and their uses
WO2007080470A3 (en) A method for the purification of levetiracetam
CN101006044B (en) Purification method of terephthal aldehyde
MX2010004367A (en) Process for producing aliphatic carboxylic acid amide.
CN101768066A (en) Preparation method and application of trichloroacetone with high purity
WO2010049697A3 (en) Pure carboxilic acid filtration
CN104844524A (en) Synthetic method of ambrisentan
WO2007017894B1 (en) PREPARATION OF NOVEL CRYSTALLINE η(ETA) FORM OF PERINDOPRIL ERBUMINE
TW200519090A (en) Process for producing high purity 3, 5-dihydroxy-6-heptenoic acid derivative
CN103420882A (en) Method for preparing L-methionine
CN100491341C (en) Separating and purifying method for N-methyl-2-(4-phenoxy phenoxy)-2-chloroacetamide
WO2017221213A1 (en) Processes for the preparation of eluxadoline
CN108892641B (en) Preparation method of lappaconitine hydrobromide
CN101475529B (en) Mixed solvent crystallization resolution method for tetrahydrochysene isoquinoline racemate

Legal Events

Date Code Title Description
NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct app. not ent. europ. phase

Ref document number: 08843339

Country of ref document: EP

Kind code of ref document: A2